{
    "ticker": "DXFFY",
    "name": "Daxor Corporation",
    "description": "Daxor Corporation is a medical instrumentation and biotechnology company that specializes in the development of innovative diagnostic tools for the healthcare industry. Founded in 1983, Daxor is best known for its flagship product, the BVA-100, a blood volume analyzer that measures blood volume and assists in the diagnosis and management of various medical conditions, particularly heart failure and fluid overload. The BVA-100 provides critical information that can help clinicians make informed decisions regarding patient treatment and management. Daxor aims to improve patient outcomes through its advanced technology, which offers real-time insights into blood volume status, thereby enhancing the accuracy of fluid management in critical care settings. Additionally, the company is involved in research and development initiatives to expand its product offerings and improve existing diagnostic tools. Daxor\u2019s commitment to innovation and quality in medical diagnostics underscores its mission to enhance patient care and support healthcare professionals in delivering effective treatment.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "New York City, New York, USA",
    "founded": "1983",
    "website": "http://www.daxor.com",
    "ceo": "Dr. Michael O. G. A. M. S. A. Daxor",
    "social_media": {
        "twitter": "https://twitter.com/DaxorCorp",
        "linkedin": "https://www.linkedin.com/company/daxor-corporation"
    },
    "investor_relations": "http://www.daxor.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Michael O. G. A. M. S. A. Daxor",
            "position": "CEO"
        },
        {
            "name": "Robert W. Daxor",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Devices",
            "products": [
                "BVA-100"
            ]
        }
    ],
    "seo": {
        "meta_title": "Daxor Corporation | Innovative Medical Diagnostics",
        "meta_description": "Explore Daxor Corporation, a leader in medical instrumentation and biotechnology focusing on advanced diagnostic tools for healthcare. Learn about Daxor's commitment to enhancing patient care.",
        "keywords": [
            "Daxor",
            "Medical Diagnostics",
            "Blood Volume Analyzer",
            "Healthcare Technology",
            "BVA-100"
        ]
    },
    "faq": [
        {
            "question": "What is Daxor known for?",
            "answer": "Daxor is known for its innovative blood volume analyzer, the BVA-100, which aids in diagnosing and managing heart failure and fluid overload."
        },
        {
            "question": "Who is the CEO of Daxor?",
            "answer": "Dr. Michael O. G. A. M. S. A. Daxor is the CEO of Daxor Corporation."
        },
        {
            "question": "Where is Daxor headquartered?",
            "answer": "Daxor is headquartered in New York City, New York, USA."
        },
        {
            "question": "What products does Daxor offer?",
            "answer": "Daxor offers the BVA-100 blood volume analyzer as part of its diagnostic devices."
        },
        {
            "question": "When was Daxor founded?",
            "answer": "Daxor was founded in 1983."
        }
    ],
    "competitors": [
        "ABT",
        "MDT",
        "SYK",
        "HOLX"
    ],
    "related_stocks": [
        "PFE",
        "JNJ",
        "MRK",
        "BMY"
    ]
}